- United States
- /
- Healthcare Services
- /
- OTCPK:NVTA.Q
Where Invitae Corporation (NYSE:NVTA) Stands In Terms Of Earnings Growth Against Its Industry
Examining Invitae Corporation's (NYSE:NVTA) past track record of performance is a valuable exercise for investors. It enables us to understand whether the company has met or exceed expectations, which is a powerful signal for future performance. Below, I will assess NVTA's latest performance announced on 30 September 2017 and weigh these figures against its longer term trend and industry movements. See our latest analysis for Invitae
Was NVTA's recent earnings decline worse than the long-term trend and the industry?
I prefer to use data from the most recent 12 months, which annualizes the most recent half-year data, or in some cases, the latest annual report is already the most recent financial year data. This allows me to examine different stocks on a similar basis, using the latest information. For Invitae, its latest trailing-twelve-month earnings is -US$107.73M, which compared to last year’s level, has become more negative. Since these figures may be somewhat short-term thinking, I have calculated an annualized five-year value for Invitae's net income, which stands at -US$70.17M. This doesn’t seem to paint a better picture, as earnings seem to have steadily been getting more and more negative over time.
What does this mean?
While past data is useful, it doesn’t tell the whole story. Companies that incur net loss is always hard to envisage what will happen in the future and when. The most valuable step is to assess company-specific issues Invitae may be facing and whether management guidance has steadily been met in the past. I suggest you continue to research Invitae to get a more holistic view of the stock by looking at:
- 1. Future Outlook: What are well-informed industry analysts predicting for NVTA’s future growth? Take a look at our free research report of analyst consensus for NVTA’s outlook.
- 2. Financial Health: Is NVTA’s operations financially sustainable? Balance sheets can be hard to analyze, which is why we’ve done it for you. Check out our financial health checks here.
- 3. Other High-Performing Stocks: Are there other stocks that provide better prospects with proven track records? Explore our free list of these great stocks here.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Simply Wall St analyst Simply Wall St and Simply Wall St have no position in any of the companies mentioned. This article is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
About OTCPK:NVTA.Q
Invitae
A medical genetics company, that provides genetic information to improve healthcare of people in the United States, Canada, and internationally.
Medium-low and slightly overvalued.
Similar Companies
Market Insights
Community Narratives


